Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Apr 28;12(1):8173.
doi: 10.4081/or.2020.8173. eCollection 2020 Apr 22.

Allogenic bone graft for femoral defect augmentation in hip revision arthroplasty: A case series

Nils Wirries  1 , Michael Skutek  1 , Marcus Örgel  2 , Stefan Budde  1 , Alexander Derksen  1 , Henning Windhagen  1 , Thilo Flörkemeier  1
Affiliations

Allogenic bone graft for femoral defect augmentation in hip revision arthroplasty: A case series

Nils Wirries et al. Orthop Rev (Pavia). .

Abstract

Cortical bone loss in revision hip arthroplasty requires an adequate stabilization to achieve a durable implant fixation. This case series shall illustrate possible indications for the use of allogenic grafts in revision hip arthroplasty. Twelve patients with femoral bone loss were treated with allografts. In addition to established clinical scores, the radiological follow-ups were analyzed for hints of implants loosening and the osteointegration of the allografts. After a mean follow-up of 3.0 years the mHHS was 61.3 points and the UCLA 3.8. One patient showed a non-progressive radiolucency around the hip implant. The osteointegration of all allogenic grafts happened on time. Up to the last follow-up no revision surgery of the hip implants and the associated femoral bone graft was observed. Allogenic bone grafts present a method for biological stabilization in situations of large femoral cortical bone defects in revision hip arthroplasty.

Keywords: Femoral bone loss; Paprowsky; allogen bone graft; defect Augmentation; revision hip arthroplasty.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: The authors declare no potential conflict of interest.

Figures

Figure 1.
Figure 1.
A bone defect about 6 x 2 cm located at the lateral femur covered by allogenic femoral bone graft and two wires.
See this image and copyright information in PMC

Similar articles

See all similar articles

References

    1. Kurtz S, Mowat F, Ong K, et al. Prevalence of primary and revision total hip and knee arthroplasty in the united states from 1990 through 2002. J Bone Joint Surg Am 2005;87:1487-97. - PubMed
    1. Kurtz S, Ong K, Lau E, et al. Projections of primary and revision hip and knee arthroplasty in the united states from 2005 to 2030. J Bone Joint Surg Am 2007;89:780-5. - PubMed
    1. Kurtz SM, Lau E, Ong K, et al. Future young patient demand for primary and revision joint replacement: National projections from 2010 to 2030. Clin Orthop Relat Res 2009;467:2606-12. - PMC - PubMed
    1. Boscainos PJ, Kellett CF, Maury AC, et al. Management of periacetabular bone loss in revision hip arthroplasty. Clin Orthop Relat Res 2007;465:159-65. - PubMed
    1. Sculco PK, Abdel MP, Lewallen DG. Management of femoral bone loss in revision total hip arthroplasty. Hip Int 2015;25:380-7. - PubMed